Physician

Wen Han, M.D.

According to 2025 Medicare claims, Wen Han, M.D. (NPI: 1104020312) practices endocrinology in the Modesto, CA market, with the plurality of this provider's patient population coming from Stanislaus, CA. This provider's primary affiliated billing organization is SUTTER VALLEY MEDICAL FOUNDATION (NPI: 1669846986; TIN: 680273974) and primary practice location at 95355-4201. Han is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Han's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 950 traditional Medicare patients, billed 24,249 HCPCS/CPT codes, and received $504,776 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 7,689 prescription claims across 906 beneficiaries totaling $2,881,020 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,158 claims. Open Payments data shows 5 records totaling $570. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $214,914 to $504,776. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,064,485 to $2,881,020. For DME billing, reported payments moved sharply higher in recent years, from $4,849 to $265,983.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$252K$505K2015 Medicare payment: $214,914 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $264,325 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $186,492 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $201,777 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $258,325 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $255,758 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $354,477 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $395,278 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $467,286 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $504,776 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156196,291$214,914
201666314,909$264,325
201771411,077$186,492
201879810,415$201,777
201992611,766$258,325
202091410,663$255,758
202192313,372$354,477
202290618,671$395,278
202394922,203$467,286
202495024,249$504,776

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.9M2015 Drug cost: $1,064,485 (USD; Tot_Drug_Cst)2016 Drug cost: $1,405,511 (USD; Tot_Drug_Cst)2017 Drug cost: $1,734,513 (USD; Tot_Drug_Cst)2018 Drug cost: $2,043,794 (USD; Tot_Drug_Cst)2019 Drug cost: $2,373,564 (USD; Tot_Drug_Cst)2020 Drug cost: $2,591,958 (USD; Tot_Drug_Cst)2021 Drug cost: $3,505,130 (USD; Tot_Drug_Cst)2022 Drug cost: $3,637,769 (USD; Tot_Drug_Cst)2023 Drug cost: $3,860,485 (USD; Tot_Drug_Cst)2024 Drug cost: $2,881,020 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155264,945$1,064,485
20166165,612$1,405,511
20176435,282$1,734,513
20186625,452$2,043,794
20198106,247$2,373,564
20208586,814$2,591,958
20219838,288$3,505,130
20229008,054$3,637,769
20239387,843$3,860,485
20249067,689$2,881,020

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$137K$274K2015 Medicare payment: $12,845 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $16,872 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $16,136 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $25,582 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $44,679 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $61,598 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $97,172 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $117,851 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $164,467 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $273,612 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015294724$12,845
2016363899$16,872
2017307858$16,136
2018329902$25,582
20193491,057$44,679
20203491,118$61,598
20214351,415$97,172
20224141,395$117,851
20233831,400$164,467
20243851,158$273,612

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more196196$122
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8181,426$90
J0897Injection, denosumab, 1 mg12612,840$21
96372Injection of drug or substance under skin or into muscle135306$12
83036Hemoglobin a1c level1212$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide32515,937$495,564
JardianceEmpagliflozin52423,701$451,908
TrulicityDulaglutide1848,104$274,078
MounjaroTirzepatide2045,999$215,176
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24117,757$198,362

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceN117410$205,794
E0784External ambulatory infusion pump, insulinYN/R46$15,648
A4238Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R35$13,189
E2103Non-adjunctive, non-implanted continuous glucose monitor or receiverN5151$11,438
A4224Supplies for maintenance of insulin infusion catheter, per weekN1239$9,851

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$570BETA BIONICS, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wen Han, M.D.?

Tedicare shows public-source Medicare data for Wen Han, M.D. (NPI 1104020312), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wen Han, M.D. have ACO affiliation data?

Wen Han, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Wen Han, M.D.?

Wen Han, M.D. is linked to SUTTER VALLEY MEDICAL FOUNDATION (billing NPI 1669846986) in the available physician profile data.

Does Wen Han, M.D. have Open Payments data?

Wen Han, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.